LILLY ENDOWMENT INC 4
4 · ELI LILLY & Co · Filed May 7, 2026
Research Summary
AI-generated summary of this filing
Eli Lilly (LLY) 10% Owner Lilly Endowment Sells $15.75M
What Happened Lilly Endowment Inc., reported as a 10% owner of Eli Lilly & Co. (LLY), disposed of a total of 15,828 shares on May 6, 2026 in open-market/private sale transactions. The filing shows two grouped dispositions: 13,620 shares at a weighted-average price of $995.23 (≈ $13,554,965) and 2,208 shares at a weighted-average price of $996.18 (≈ $2,199,572), for aggregate proceeds of about $15,754,537. This was a sale (S) — institutional selling is common and does not necessarily reflect management sentiment.
Key Details
- Transaction date: 2026-05-06 (reported on Form 4 filed 2026-05-07) — filing appears timely.
- Shares sold: 13,620 @ $995.23 (weighted avg) and 2,208 @ $996.18 (weighted avg); total = 15,828 shares.
- Proceeds: ≈ $13,554,965 and $2,199,572, total ≈ $15,754,537.
- Price ranges (per footnotes): first block sold across $995.00–$995.9963; second across $996.00–$996.46. The reported prices are weighted averages; the filer can provide per-trade breakdown on request.
- Shares owned after transaction: not specified in the provided excerpt of the filing.
Context
- Lilly Endowment is an institutional 10% owner, not an individual executive; institutional sales can reflect portfolio rebalancing or other fund-level decisions rather than insider views of company prospects.
- No option exercises, awards, gifts, or tax-withholding codes apply here — these were straight dispositions (S).
Insider Transaction Report
Form 4Exit
LILLY ENDOWMENT INC
Other
Transactions
- Sale
Common Stock
[F1]2026-05-06$995.23/sh−13,620$13,554,965→ 91,883,358 total - Sale
Common Stock
[F2]2026-05-06$996.18/sh−2,208$2,199,572→ 91,881,150 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $995.00 to $995.9963, inclusive. The reporting person undertakes to provide to Eli Lilly & Company, any security holder of Eli Lilly & Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) and (2) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $996.00 to $996.46, inclusive.
Signature
/s/ Diane M. Stenson, Vice President and Treasurer, on behalf of Lilly Endowment Inc.|2026-05-07